做还是不做微笑手术：支持性护理很重要。 - Suppr

Suppr

超能文献

To SMILE or not: supportive care matters.

作者信息

Chan Alexandre, Tang Tiffany, Ng Terence, Shih Vivianne, Tay Kevin, Tao Miriam, Quek Richard, Lim Soon Thye

出版信息

J Clin Oncol. 2012 Mar 20;30(9):1015-6; author reply 1016-7. doi: 10.1200/JCO.2011.40.7098. Epub 2012 Feb 13.

DOI:10.1200/JCO.2011.40.7098

PMID:22331933

Abstract

摘要

相似文献

To SMILE or not: supportive care matters.做还是不做微笑手术：支持性护理很重要。

J Clin Oncol. 2012 Mar 20;30(9):1015-6; author reply 1016-7. doi: 10.1200/JCO.2011.40.7098. Epub 2012 Feb 13.

Nasal extranodal peripheral NK/T-cell lymphoma treated by the protocol NK/T-cell high-dose-methotrexate L-asparaginase dexamethasone.采用NK/T细胞大剂量甲氨蝶呤、左旋门冬酰胺酶、地塞米松方案治疗的鼻外结外外周NK/T细胞淋巴瘤

Hematol Oncol Stem Cell Ther. 2011;4(1):49-50. doi: 10.1016/s1658-3876(11)50063-9.

Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.SMILE 化疗治疗初诊 IV 期、复发或难治性结外鼻型自然杀伤（NK）/T 细胞淋巴瘤的 II 期研究：NK 细胞肿瘤研究组研究。

J Clin Oncol. 2011 Nov 20;29(33):4410-6. doi: 10.1200/JCO.2011.35.6287. Epub 2011 Oct 11.

Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211.局限性鼻腔自然杀伤/T细胞淋巴瘤的同步放化疗：日本临床肿瘤学组JCOG0211研究的更新分析

J Clin Oncol. 2012 Nov 10;30(32):4044-6. doi: 10.1200/JCO.2012.45.6541. Epub 2012 Oct 8.

Efficacy of pegaspargase in extra nodal natural killer/T-cell lymphoma nasal type: A case report from China.培门冬酶治疗鼻型结外自然杀伤/T细胞淋巴瘤的疗效：来自中国的一例病例报告

J Cancer Res Ther. 2015 Jul-Sep;11(3):665. doi: 10.4103/0973-1482.140750.

[A case of nasal NK/T cell lymphoma in Africa].[非洲一例鼻NK/T细胞淋巴瘤]

Rev Laryngol Otol Rhinol (Bord). 2011;132(4-5):255-7.

Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.联合放化疗治疗鼻型自然杀伤（NK）/T细胞淋巴瘤：阐明全身化疗的意义

Oral Oncol. 2008 Jan;44(1):23-30. doi: 10.1016/j.oraloncology.2006.11.020. Epub 2007 Feb 15.

Comparative Study of L-Asparaginase-Based LOP Regimen Over CHOP Regimen Before Radiotherapy for Stage IIE Extranodal Nasal Type NK/T Cell Lymphoma: A Study of 2 Centers.放疗前基于左旋门冬酰胺酶的LOP方案与CHOP方案治疗ⅡE期结外鼻型NK/T细胞淋巴瘤的对比研究：一项双中心研究

Clin Lymphoma Myeloma Leuk. 2017 Mar;17(3):152-158. doi: 10.1016/j.clml.2016.12.003. Epub 2017 Jan 10.

Extranodal sinonasal natural killer/T-cell lymphoma presenting as chronic sinusitis and necrotic wound infection.表现为慢性鼻窦炎和坏死性伤口感染的结外鼻型自然杀伤/ T细胞淋巴瘤

J Craniofac Surg. 2009 Nov;20(6):2095-6. doi: 10.1097/SCS.0b013e3181bec5bb.

Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.同步放疗与每周顺铂化疗后行VIPD化疗治疗新诊断的IE期至IIE期鼻型结外NK/T细胞淋巴瘤的II期试验：淋巴瘤生存改善联盟研究

J Clin Oncol. 2009 Dec 10;27(35):6027-32. doi: 10.1200/JCO.2009.23.8592. Epub 2009 Nov 2.

引用本文的文献

Clinical efficacy of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) in the initial treatment of advanced stage (stage III-IV) extranodal NK/T-cell lymphoma, and its correlation with Epstein-Barr virus.顺铂、地塞米松、吉西他滨和聚乙二醇天冬酰胺酶（DDGP）方案在晚期（Ⅲ-Ⅳ期）结外NK/T细胞淋巴瘤初始治疗中的临床疗效及其与EB病毒的相关性

Cancer Manag Res. 2019 Apr 24;11:3555-3564. doi: 10.2147/CMAR.S191929. eCollection 2019.

Novel findings from the Asian Lymphoma Study Group: focus on T and NK-cell lymphomas.亚洲淋巴瘤研究组的新发现：聚焦于T细胞和NK细胞淋巴瘤。

Int J Hematol. 2018 Apr;107(4):413-419. doi: 10.1007/s12185-018-2406-6. Epub 2018 Jan 29.

Current treatment approaches for NK/T-cell lymphoma.NK/T细胞淋巴瘤的当前治疗方法。

J Clin Exp Hematop. 2017 Dec 27;57(3):98-108. doi: 10.3960/jslrt.17018. Epub 2017 Jul 6.

[Efficacy of GLIDE chemotherapy for patients with newly diagnosed advanced-stage or relapsed/refractory extranodal natural killer cell lymphoma].[GLIDE化疗方案对新诊断的晚期或复发/难治性结外自然杀伤细胞淋巴瘤患者的疗效]

Zhonghua Xue Ye Xue Za Zhi. 2016 Sep 14;37(9):751-755. doi: 10.3760/cma.j.issn.0253-2727.2016.09.005.

The DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen for treatment of extranodal natural killer (NK)/T-cell lymphoma, nasal type.用于治疗鼻型结外自然杀伤（NK）/T细胞淋巴瘤的DDGP（顺铂、地塞米松、吉西他滨和聚乙二醇天冬酰胺酶）方案。

Oncotarget. 2016 Sep 6;7(36):58396-58404. doi: 10.18632/oncotarget.11135.

Trial of LVDP regimen (L-asparaginase, etoposide, dexamethasone, and cisplatin, followed by radiotherapy) as first-line treatment for newly diagnosed, stage III/IV extranodal natural killer/T cell lymphoma.左旋门冬酰胺酶、依托泊苷、地塞米松和顺铂方案（LVDP方案）序贯放疗作为初治Ⅲ/Ⅳ期结外自然杀伤/T细胞淋巴瘤一线治疗的试验

Med Oncol. 2015 Feb;32(2):435. doi: 10.1007/s12032-014-0435-4. Epub 2015 Jan 9.

Combined therapy in untreated patients improves outcome in nasal NK/T lymphoma: results of a clinical trial.未治疗患者的联合治疗可改善鼻腔 NK/T 淋巴瘤的预后：一项临床试验结果。

Med Oncol. 2013;30(3):637. doi: 10.1007/s12032-013-0637-1. Epub 2013 Jun 25.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验